417 related articles for article (PubMed ID: 37441083)
21. Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function.
Gassmann H; Schneider K; Evdokimova V; Ruzanov P; Schober SJ; Xue B; von Heyking K; Thiede M; Richter GHS; Pfaffl MW; Noessner E; Stein LD; Sorensen PH; Burdach SEG; Thiel U
Cells; 2021 Aug; 10(8):. PubMed ID: 34440851
[TBL] [Abstract][Full Text] [Related]
22. Tumor cell-derived LC3B
Chen YQ; Man ZS; Zheng L; Zhang Y; Zhao CW; Ma YT; Zhou J; Wang P; Yu Y; Gu F; Niu GP
Clin Immunol; 2024 Apr; 261():109925. PubMed ID: 38310993
[TBL] [Abstract][Full Text] [Related]
23. Detection of the interactions of tumour derived extracellular vesicles with immune cells is dependent on EV-labelling methods.
Loconte L; Arguedas D; El R; Zhou A; Chipont A; Guyonnet L; Guerin C; Piovesana E; Vázquez-Ibar JL; Joliot A; Théry C; Martín-Jaular L
J Extracell Vesicles; 2023 Dec; 12(12):e12384. PubMed ID: 38031976
[TBL] [Abstract][Full Text] [Related]
24. Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast Cancer.
Moloney BM; Gilligan KE; Joyce DP; O'Neill CP; O'Brien KP; Khan S; Glynn CL; Waldron RM; Maguire CM; Holian E; Naughton E; Elhadi M; Grealish AB; Malone C; McDermott E; Dockery P; Ritter T; Prina-Mello A; Kerin MJ; Dwyer RM
Cells; 2020 Jan; 9(1):. PubMed ID: 31936142
[TBL] [Abstract][Full Text] [Related]
25. Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome.
Tkach M; Thalmensi J; Timperi E; Gueguen P; Névo N; Grisard E; Sirven P; Cocozza F; Gouronnec A; Martin-Jaular L; Jouve M; Delisle F; Manel N; Rookhuizen DC; Guerin CL; Soumelis V; Romano E; Segura E; Théry C
Proc Natl Acad Sci U S A; 2022 Apr; 119(17):e2107394119. PubMed ID: 35439048
[TBL] [Abstract][Full Text] [Related]
26. Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma.
Tey SK; Wong SWK; Chan JYT; Mao X; Ng TH; Yeung CLS; Leung Z; Fung HL; Tang AHN; Wong DKH; Mak LY; Yuen MF; Sin CF; Ng IO; Ma SKY; Lee TKW; Cao P; Zhong K; Gao Y; Yun JP; Yam JWP
J Hepatol; 2022 Apr; 76(4):883-895. PubMed ID: 34922977
[TBL] [Abstract][Full Text] [Related]
27. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR
J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling.
Wang S; Li J; Hong S; Wang N; Xu S; Yang B; Zheng Y; Zhang J; Pan B; Hu Y; Wang Z
J Exp Clin Cancer Res; 2024 Apr; 43(1):121. PubMed ID: 38654356
[TBL] [Abstract][Full Text] [Related]
29. Extracellular vesicles containing PD-L1 contribute to CD8+ T-cell immune suppression and predict poor outcomes in small cell lung cancer.
Dou X; Hua Y; Chen Z; Chao F; Li M
Clin Exp Immunol; 2022 May; 207(3):307-317. PubMed ID: 35553630
[TBL] [Abstract][Full Text] [Related]
30. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
[TBL] [Abstract][Full Text] [Related]
31. Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells.
Ozawa PMM; Alkhilaiwi F; Cavalli IJ; Malheiros D; de Souza Fonseca Ribeiro EM; Cavalli LR
Breast Cancer Res Treat; 2018 Dec; 172(3):713-723. PubMed ID: 30173296
[TBL] [Abstract][Full Text] [Related]
32. Proteomic Profiling of Extracellular Vesicles Released by Leptin-Treated Breast Cancer Cells: A Potential Role in Cancer Metabolism.
Gelsomino L; Barone I; Caruso A; Giordano F; Brindisi M; Morello G; Accattatis FM; Panza S; Cappello AR; Bonofiglio D; Andò S; Catalano S; Giordano C
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361728
[TBL] [Abstract][Full Text] [Related]
33. αvβ1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells: A mechanism mediated by galectin-3.
Zhang DX; Dang XTT; Vu LT; Lim CMH; Yeo EYM; Lam BWS; Leong SM; Omar N; Putti TC; Yeh YC; Ma V; Luo JY; Cho WC; Chen G; Lee VKM; Grimson A; Le MTN
J Extracell Vesicles; 2022 Aug; 11(8):e12234. PubMed ID: 35923105
[TBL] [Abstract][Full Text] [Related]
34. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
35. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
[TBL] [Abstract][Full Text] [Related]
36. Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine.
Monguió-Tortajada M; Roura S; Gálvez-Montón C; Pujal JM; Aran G; Sanjurjo L; Franquesa M; Sarrias MR; Bayes-Genis A; Borràs FE
Theranostics; 2017; 7(2):270-284. PubMed ID: 28042333
[TBL] [Abstract][Full Text] [Related]
37. Preliminary investigation of extracellular vesicles in mammary cancer of dogs and cats: Identification and characterization.
Sammarco A; Finesso G; Cavicchioli L; Ferro S; Caicci F; Zanetti R; Sacchetto R; Zappulli V
Vet Comp Oncol; 2018 Dec; 16(4):489-496. PubMed ID: 29851284
[TBL] [Abstract][Full Text] [Related]
38. Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD.
Nagasawa M; Mitsuiki N; Yanagimachi M; Yamamoto M; Fukuda T; Miura O; Oba R; Igarashi A; Nagata K; Morio T
Int J Hematol; 2021 Jun; 113(6):910-920. PubMed ID: 33683652
[TBL] [Abstract][Full Text] [Related]
39. EV PD-L1 is Correlated With Clinical Features and Contributes to T Cell Suppression in Pediatric Thyroid Cancer.
Wang G; He L; Wang S; Zhang M; Li Y; Liu Q; Sun N; Zhang X; Liu Y; Zhang J; Tai J; Ni X
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32459310
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of plasma LC3B
Chen YQ; Zheng L; Zhou J; Wang P; Wang L; Zhang Y; Man ZS; Chen YH; Gu F; Niu GP
Int Immunopharmacol; 2022 Jul; 108():108760. PubMed ID: 35398623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
